Dominari Holdings Inc
DOMH
Get informed when a big investor buys or sells
+ FollowMarket Cap$58.34M
Close$
$2.52
1.5% downside
Current Fair Value
1.5% downsideOvervalued by 1.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $58.34 Million |
|---|---|
| Enterprise Value | $49.46 Million |
| Dividend Yield | $0.96 (37.31%) |
| Earnings per Share | $-1.57 |
| Beta | 0.87 |
| Outstanding Shares | 22,754,753 |
Return
| Return on Equity | -315.45% |
|---|---|
| Return on Assets | -120.00% |
| Return on Invested Capital | 201.67% |
Valuation & Multiples
| P/E Ratio | -0.74 |
|---|---|
| PEG | 0.57 |
| Price to Sales | 0.51 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.37 |
| Enterprise Value to EBIT | 0.59 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$30.08 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.68
Average shareholder expectationRevenue Estimate
$18.58 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 25,200▼ 69.57% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.89%▼ 2.12% |
|---|---|
| Total Invested | $5.22M▼ 32.53% |
| Investors Holding | 31▼ 9.00% |
ESG Score
No data
About Dominari Holdings Inc
5 employees
CEO: Anthony Hayes AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading universities and res...